Cannabis in Microdoses Improves Non-Motor Symptoms of Parkinson's, Brazilian Study Indicates in Six Patients
The study had few patients and did not use a placebo-controlled group, but it was conducted on humans and the results suggest possible benefits of cannabis against the disease in non-motor symptoms.
A recent Brazilian study published in Frontiers revealed that the use of microdoses of cannabis may alleviate non-motor symptoms of Parkinson's disease, such as cognitive and sleep disturbances. The research analyzed six patients who used low doses of cannabis oil and showed promising results in sleep quality. Additionally, the participants did not report adverse side effects, indicating a potentially favorable safety profile.
Small Doses, Big Effects
The study participants self-administered 0.5 mL of cannabis extract for 90 days. They were divided into two groups: one used the extract containing 250 micrograms of THC, and the other used the extract containing 1000 micrograms of THC, both with higher proportions of THC than CBD. The researchers observed that even in minimal amounts, THC showed therapeutic potential, positively impacting the patients' well-being without causing adverse effects.
Another relevant point was the patients' response to the microdoses. The researchers identified that the beneficial effects occurred without cognitive impairment or significant changes in the participants' perception. This suggests that small amounts of THC may be a viable option for managing non-motor symptoms in Parkinson's.
Mechanisms of Cannabidiol in Parkinson's
An Australian randomized clinical trial had also identified that THC can enhance patients' mood and sleep, providing a more comprehensive approach to treating the disease. Previous studies have indicated that the endocannabinoid system plays a crucial role in regulating processes such as inflammation and neuroprotection, reinforcing the therapeutic potential of cannabis in Parkinson's.
Furthermore, the researchers highlight that the effects of CBD seem to be linked to its ability to modulate neurotransmitters like dopamine and serotonin, which are essential in motor and emotional control. This suggests that the compound may have positive impacts on both the classic symptoms of the disease and psychological aspects, such as anxiety and depression, that affect many patients.
What to Expect in the Future?
Despite the promising advances, experts emphasize that more studies with larger samples are needed to validate the efficacy and safety of cannabis use in treating Parkinson's. For those interested in treatment, the recommendation is to seek guidance from specialized health professionals to evaluate the best approach according to each case. Scientists also stress that more research is essential to determine the ideal dosage and specific mechanisms of action of cannabinoids in Parkinson's.
Another important point is the need for regulation and safe access to cannabis-based products. While some countries already allow the medicinal use of the plant for neurodegenerative diseases, in others, regulatory barriers still hinder the adoption of this therapeutic alternative. With the advancement of research, it is hoped that new guidelines can expand treatment options for patients with Parkinson's and other neurological conditions.